Florida-based company that deals with cancer diagnostics Oncosure announced on Wednesday that it has launched its Rapid Cancer Screening Test, making early detection accessible to everyone.
It is claimed that the Oncosure test can screen for all types of cancer with one blood sample and that it provides a method to detect cancer at its earliest stages, even as early as stage -1 and delivers accurate, definitive results within hours. The company says that it also helps in monitoring ongoing cancer treatments, helping assess whether therapies are effective.
Jason Andrews, Oncosure vice president, said, 'One blood draw, all cancers--this is the future of cancer screening. Cancer doesn't wait for symptoms, and neither should you. Our test empowers everyone to screen for any type of cancer with a single, non-invasive test.'
Lilly expands manufacturing footprint in Ireland
Sanofi, RadioMedix and Orano Med partner on rare cancer treatment
Johnson & Johnson receives approval from FDA for TREMFYA (guselkumab)
NeoGenomics to present breakthrough data at ESMO 2024 on ctDNA and NGS for cancer diagnostics
Merck's GARDASIL 9 shows promise in preventing HPV infection in Japanese males
Pheon Therapeutics names new independent, non-executive director
Solu Therapeutics names new chief medical officer
Tyra Biosciences names new chief medical officer
Arecor reports positive Phase I Results for AT278 insulin at EASD 2024